Superstar investor Cathie Wood is increasing her bet on a cutting-edge technology that could transform the treatment of many diseases. I'm talking about gene editing.

Wood has been progressively increasing her stake in specialist Intellia Therapeutics (NASDAQ: NTLA) since December. But she's picked up the pace of Intellia buys over the past month and scooped up more than 434,000 shares.

The company's stock has dropped about 17% since its peak in July, so Wood clearly saw this as an opportunity to add to her position in the biotech company. Considering Wood's strengths in picking out top innovators -- she was an early believer in electric-vehicle giant Tesla, for example -- you may be tempted to follow her latest moves. But should you, too, pile into Intellia shares right now?

Continue reading

Source Fool.com